| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 26.31B | 25.26B | 27.57B | 25.44B | 23.89B |
| Gross Profit | 8.32B | 8.90B | 9.80B | 10.26B | 12.44B |
| EBITDA | 9.38B | 8.73B | 12.83B | 7.11B | 9.80B |
| Net Income | 5.65B | 6.30B | 9.26B | 9.24B | 13.20B |
Balance Sheet | |||||
| Total Assets | 539.38B | 531.24B | 542.55B | 529.79B | 550.30B |
| Cash, Cash Equivalents and Short-Term Investments | 23.12B | 18.77B | 22.11B | 11.74B | 11.34B |
| Total Debt | 163.91B | 154.22B | 161.69B | 150.09B | 159.48B |
| Total Liabilities | 198.50B | 190.66B | 198.45B | 184.64B | 198.13B |
| Stockholders Equity | 322.46B | 322.15B | 326.54B | 327.95B | 335.02B |
Cash Flow | |||||
| Free Cash Flow | 12.32B | 15.30B | 14.46B | 7.95B | -54.16B |
| Operating Cash Flow | 12.32B | 15.30B | 14.46B | 11.13B | 685.00M |
| Investing Cash Flow | -8.38B | -1.87B | 16.00M | 12.15B | -50.04B |
| Financing Cash Flow | -4.75B | -21.20B | -5.42B | -21.30B | 52.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | HK$147.18B | 24.10 | 1.76% | 6.20% | 2.00% | -10.22% | |
62 Neutral | HK$22.45B | 7.71 | 1.39% | 5.62% | -11.43% | -15.07% | |
61 Neutral | HK$5.26B | 6.75 | 6.10% | 5.22% | 477.74% | 332.86% | |
59 Neutral | HK$13.35B | -6.82 | -3.14% | 5.93% | 80.71% | 4.60% | |
45 Neutral | HK$1.69B | -0.83 | -3.56% | ― | 72.75% | 25.44% | |
40 Underperform | HK$21.06B | -1.70 | -9.54% | ― | -68.23% | 29.26% |